Login / Signup

Successful management of dry eye disease with a new eye drop formulation combining hyaluronic acid, trehalose, and N-acetyl-aspartyl-glutamic acid (NAAGA).

L El FekihM KhairallahH Ben AmorA MahmoudF ChiambarettaR Messaoud
Published in: Journal francais d'ophtalmologie (2024)
Management of moderate-to-severe DED patients with the new formulation T2769, combining NAAGA to HA and trehalose, led to rapid and significant improvements in dry eye signs and symptoms with good tolerability.
Keyphrases
  • hyaluronic acid
  • drug delivery
  • early onset
  • randomized controlled trial
  • clinical trial
  • physical activity